Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

American Journal of Cardiology

Volumn 93, Issue 9, 2004, Pages 1081-1085

  Tarantini, Giuseppe ^a,b   Ramondo, Angelo ^a   Napodano, Massimo ^a   Bilato, Claudio ^a   Isabella, Gianbattista ^a   Razzolini, Renato ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; STROKE VOLUME; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 1942532170     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.031     Document Type: Article

References (15)

1. Hasdai D., Topol E.J., Califf R.M., Berger P.B., Holmes D.R. Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet. 356:2000;749-756.
2. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 312:1985;932-936.
3. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in the collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subject. J Am Coll Cardiol. 5:1985;587-592.
4. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Circulation. 97:1998;2302-2306.
5. Henriques J.P., Zijlstra F., van't Hof A.W., de Boer M.J., Dambrink J.H., Gosselink M., Hoorntje J.C., Suryapranata H. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 107:2003;2115-2119.
6. Hudson M.P., Granger C.B., Topol E.J., Pieper K.S., Armstrong P.W., Barbash G.I., Guerci A.D., Vahanian A., Califf R.M., Ohman E.M. Early reinfarction after fibrinolysis. Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (alteplase) for Occluded coronary arteries (GUSTO I) and Global Use of Strategies To open Occluded coronary arteries (GUSTO III) trials. Circulation. 104:2001;1229-1235.
7. Hasdai D., Califf R.M., Thompson T.D., Hochman J.S., Ohman E.M., Pfisterer M., Bates E.R., Vahanian A., Armstrong P.W., Criger D.A., Topol E.J., Holmes D.R. Jr. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol. 35:2000;136-143.
8. Hochman J.S., Sleeper L.A., White H.D., Dzavik V., Wong S.C., Menon V., Webb J.G., Steingart R., Picard M.H., Menegus M.A., et al. One year survival following early revascularization for cardiogenic shock. JAMA. 285:2001;190-192.
9. Moosvi A.R., Khaja F., Villanueva L., Gheorghiade M., Douthat L., Goldstein S. Early revascularization improves survival in cardiogenic shock complication acute myocardial infarction. J Am Coll Cardiol. 19:1992;907-914.
10. Eltchaninoff H., Simpfendorfer C., Franco I., Raymond R.E., Casale P.N., Whitlow P.L. Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock a retrospective study comparing coronary angioplasty with medical treatment. Am Heart J. 130:1995;459-464.
11. Webb J.G., Sanborn T.A., Sleeper L.A., Carere R.G., Buller C.E., Slater J.N., Baran K.W., Koller P.T., Talley J.D., Porway M., Hochman J.S., SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial registry. Am Heart J. 141:2001;964-970.
12. Claeys M.J., Bosmans J., Veenstra L., Jorens P., DeRaedt H., Vrints C.J. Determinant and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction. Circulation. 99:1999;1972-1977.
13. Lakatta E.G., Yin F.C.P. Myocardial aging functional alterations and related cellular mechanisms. Am J Physiol. 242:(11):1982;H927-H941. Heart Circ Physiol.
14. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., White H.D., Talley J.D., Buller C.E., Jacobs A.K., Slater J.N., Col J., McKinlay S.M., LeJemtel T.H. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 341:1999;625-634.
15. Williams S.G., Wright D.J., Tan L.B. Management of cardiogenic shock complicating acute myocardial infarction towards evidence based medical practice. Heart. 83:2000;621-626.